ROBIN BANSAL: Open Payments
NPI 1659932333 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 31 payments from 8 companies in 2025. Trend: 2023 $400 · 2024 $698 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $226 |
| Exact Sciences Corporation | 6 | $157 |
| Lilly USA, LLC | 7 | $128 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Novo Nordisk Inc | 2 | $43 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
Products named: Cologuard Collection Kit, AIRSUPRA, BREZTRI, MOUNJARO, GARDASIL 9, JARDIANCE, SHINGRIX, Rybelsus.
Industry payments across CT — which companies pay providers there.
